All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Security
Security
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

AI Drug Discovery Startup Chai Discovery Attracts Pfizer, Eli Lilly; Seeks $400M at $3.4B Valuation

By

Amy Feldman

1mo ago· 11 min readenNews

Summary

AI drug discovery startup Chai Discovery, founded just 15 months ago, released an antibody-designing AI model that generated intense interest from nearly 20 pharmaceutical companies. The startup is now working with major drugmakers including Pfizer and Eli Lilly to use its AI for finding new therapies, and is in talks to raise $400 million at a $3.4 billion valuation. The article highlights how AI is poised to disrupt the costly and time-intensive drug discovery process, where a single drug typically costs over $1 billion to develop.

Source

bskyAI Drug Discovery Startup Chai Discovery Attracts Pfizer, Eli Lilly; Seeks $400M at $3.4B Valuationforbes.com

Key quotes

· 2 pulled
It was like we dropped a bomb on the field
People were messaging on LinkedIn at 2 a.m., saying, 'I am so excited I can't sleep.'
Snippet from the RSS feed
Chai Discovery is working with major drugmakers to use its latest antibody AI model to find new therapies. Now it’s in talks to raise $400 million more VC funding at a $3.4 billion valuation, Forbes has learned.

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.